If this happens, Maharashtra will be the first state to pass such a law, the official added.
The law and judiciary department is examining the draft bill, which is likely to be tabled during the Budget session of the state Legislature, slated to be held in February next year.
"As per the provisions of the draft bill, if the allegations of taking commission are proved, the accused will face a jail term of up to two years and penalty of up to Rs one lakh," the official said.
"Prescribing the medicines of a particular pharma company for monetary gains is also a part of it," the official said.
If the law comes into force, a patient will be able to lodge a complaint against the doctor or the hospital concerned. For a first-time offender, there is a penal provision of one-year imprisonment and a fine of Rs 50,000.
A repeat offence will attract a two-year prison term and a fine of Rs one lakh. Also, the licence of the doctor or hospital would be cancelled, the official said.
"The medical expenses will come down. The draft bill is ready and the government plans to introduce it in the Budget session," he said.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
